menu Search
Cefisal-200

Cefisal-200

cefixime

Manufacturer:

GXI

Distributor:

Metro Drug
Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing
Concise Prescribing Info
Contents
Cefixime
Indications/Uses
URTI eg, otitis media; & other URTI where the causative organism is known or suspected to be resistant to other commonly used antibiotics, or where treatment failure may carry significant risk. Lower resp tract infection eg, bronchitis. UTI eg, cystitis, cystourethritis, uncomplicated pyelonephritis. Infections caused by commonly occurring pathogens including Strep pneumoniae, Strep pyogenes, E. coli, Proteus mirabilis, Klebsiella spp, H. influenzae (β-lactamase +ve & -ve), Branhamella catarrhalis (β-lactamase +ve & -ve) & Enterobacter spp.
Click to view Cefisal-200 detailed prescribing information
Dosage/Direction for Use
Adult, elderly, & adolescent ≥12 yr 200-400 mg daily as a single dose according to severity of infection (400 mg may also be taken as 2 divided doses). Duration of treatment: 7 days. May be continued for up to 14 days if required. Childn 6 mth-11 yr 8 mg/kg/day as a single dose or in 2 divided doses. Adult w/ CrCl <20 mL/min; patient who is maintained on chronic ambulatory peritoneal dialysis or hemodialysis 200 mg once daily should not be exceeded.
Click to view Cefisal-200 detailed prescribing information
Overdosage
View Cefisal-200 overdosage for action to be taken in the event of an overdose.
Administration
May be taken with or without food.
Contraindications
Hypersensitivity to cefixime or other cephalosporin antibiotics. Previous, immediate &/or severe hypersensitivity reaction to penicillin or any β-lactam antibiotic.
Click to view Cefisal-200 detailed prescribing information
Special Precautions
Discontinue use if severe hypersensitivity reactions or anaphylactic reactions occur; in patients who develop severe diarrhea during or after use of cefixime. Caution in patients who have shown hypersensitivity to other drugs. Cross-allergenicity may occur between cephalosporins, penicillins & β-lactam antibiotics. Prolonged use may result in overgrowth of non-susceptible organisms. Consider pseudomembranous colitis in patients who develop diarrhea in association w/ use of broad-spectrum antibiotics. Caution in patients w/ CrCl <20 mL/min. Not to be used in pregnant mothers unless considered essential. Not to be prescribed to breastfeeding mothers until further clinical experience is available. Not recommended in ped & adolescent w/ renal insufficiency.
Click to view Cefisal-200 detailed prescribing information
Use In Pregnancy & Lactation
Click to view Cefisal-200 detailed prescribing information
Adverse Reactions
Diarrhea.
Click to view Cefisal-200 detailed prescribing information
Drug Interactions
False +ve reaction for glucose in urine may occur w/ Benedict's or Fehling's soln or Cu sulphate test tab. False +ve direct Coombs' test. Increases in prothrombin time w/ anticoagulation therapy.
Click to view Cefisal-200 detailed prescribing information
Storage
View Cefisal-200 storage conditions for details to ensure optimal shelf-life.
Description
View Cefisal-200 description for details of the chemical structure and excipients (inactive components).
Action
View Cefisal-200 mechanism of action for pharmacodynamics and pharmacokinetics details.
MIMS Class
Cephalosporins
ATC Classification
J01DD08 - cefixime ; Belongs to the class of third-generation cephalosporins. Used in the systemic treatment of infections.
Regulatory Classification
Rx
Presentation/Packing
Form
Cefisal-200 FC tab 200 mg
Packing/Price
30's (P74.52/film-coated tab)